![Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof](/docs/US/2024-10-08/US12110298B2/abs.jpg.600x600.jpg)
- Patent Title: Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
-
Application No.: US18369272Application Date: 2023-09-18
-
Publication No.: US12110298B2Publication Date: 2024-10-08
- Inventor: Mathew M. Mulhern , Fredrik Lars Nordstrom , Ahmad Y. Sheikh
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: WOMBLE BOND DICKINSON (US) LLP
- Agent Danielle L. Herritt; Scott R. Breining
- Main IPC: C07D487/14
- IPC: C07D487/14 ; A61K9/00 ; A61K31/4985 ; A61K47/02 ; A61K47/12 ; A61K47/38 ; C07D487/04
![Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof](/abs-image/US/2024/10/08/US12110298B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
Public/Granted literature
Information query
